Heat Shock Protein Studies in Type 1 and Type 2 Diabetes and Human Islet Cell Culture

1995 ◽  
Vol 12 (7) ◽  
pp. 595-599 ◽  
Author(s):  
D.F. Child ◽  
C.P. Williams ◽  
R.P. Jones ◽  
P.R. Hudson ◽  
M. Jones ◽  
...  
2017 ◽  
Vol 13 (2) ◽  
pp. 296-301
Author(s):  
Anbreen Iqbal ◽  
Muhammad Imran Qadir ◽  
Muhammad Asif

Diabetes is not one disease but rather is a heterogeneous group of syndromes characterized by an elevation of fasting blood glucose caused by a relative or absolute deficiency in insulin. The two main types of diabetes occur, type-1 is insulin dependent diabetes mellitus and type-2 is non insulin dependent diabetes mellitus. In type-1 body does not produce insulin and about 10% of all diabetic patients are affected. In type-2 diabetes imbalance of insulin and glucose occur and there are about 90% cases for type-2 diabetes. Gestational diabetes is also a type of diabetes and it is found mostly in women’s who are pregnant later such women’s are affected with type-2 diabetes and about 40% cases are studied. Different countries are affected at high level from diabetes. For the treatment of diabetes different techniques like insulin injection, oral vaccination, pancreas transplantation, transplantation of encapsulated islet cells, gene therapy technique and islet cell transplantation are used. All techniques have some advantages and disadvantages, but the encapsulated islet cell transplantation technique is promising with minimum complications. 


2009 ◽  
Vol 85 (2) ◽  
pp. 208-212 ◽  
Author(s):  
T. Imatoh ◽  
T. Sugie ◽  
M. Miyazaki ◽  
S. Tanihara ◽  
M. Baba ◽  
...  

Gene ◽  
2012 ◽  
Vol 498 (1) ◽  
pp. 107-111 ◽  
Author(s):  
Manouchehr Nakhjavani ◽  
Afsaneh Morteza ◽  
Firuzeh Asgarani ◽  
Omid Khalilzadeh ◽  
Zaniar Ghazizadeh ◽  
...  

2020 ◽  
Author(s):  
Xinru Wang ◽  
Jie Shi ◽  
Bin Lu ◽  
Weiwei Zhang ◽  
Yehong Yang ◽  
...  

Abstract Background Heat shock protein 27 (HSP27) has been proposed as a vital protective factor in atherosclerosis. The objective of the present study was to evaluate the association between circulating HSP27 and intima–media thickness (IMT) of the common carotid artery in individuals with type 2 diabetes and to determine whether HSP27 represents an independent marker for subclinical atherosclerosis in this patient population. Methods We performed a cross-sectional community-based study consisting in 186 Chinese subjects with a median duration of diabetes of 8.2 years who underwent carotid ultrasound IMT measurement. Serum HSP27 levels were assessed by ELISA. Results Serum HSP27 levels were significantly higher in the IMT (+, >1.0 mm) group than in the IMT (-, ≤1.0 mm) group, with the median value of 8.80 ng/mL (5.62–12.25) and 6.93 ng/mL (4.23–9.60), respectively ( P =0.006). The discriminative value of HSP27 to evaluate IMT was 7.16 ng/mL and the area under the curve was 0.72 (95%CI=0.64–0.80, P=0.0065). Spearman's rank correlation analysis demonstrated that the concentrations of circulating HSP27 were positively correlated with carotid IMT ( r =0.198, P =0.007) and blood urea nitrogen ( r =0.170, P <0.05). Furthermore, in the logistic model, serum HSP27 levels were found to be independent predictors of carotid IMT in type 2 diabetic patients after adjustment for onset age of diabetes, blood pressure, total cholesterol and C-reactive protein. (OR=1.085, P =0.022). Conclusions Circulating HSP27 level, positively correlates with carotid IMT, is an independent predictor for early atherosclerotic changes in diabetes, and may represent a novel marker of subclinical atherosclerosis in type 2 diabetes.


2018 ◽  
Vol 24 (1) ◽  
pp. 69-75 ◽  
Author(s):  
Hamid Alemi ◽  
Pegah Khaloo ◽  
Soghra Rabizadeh ◽  
Mohammad Ali Mansournia ◽  
Hossein Mirmiranpour ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document